Corrigendum: Monocyte-induced recovery of inflammationassociated hepatocellular dysfunction in a biochip-based human liver model (Scientific Reports (2018) DOI: 10.1038/srep21868);Monocyte-induced recovery of inflammation-associated hepatocellular dysfunction in a biochip-based human liver model

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Gröger, Marko ^a   Rennert, Knut ^a   Giszas, Benjamin ^a   Weiß, Elisabeth ^a   Dinger, Julia ^a   Funke, Harald ^a   Kiehntopf, Michael ^a   Peters, Frank T ^a   Lupp, Amelie ^a   Bauer, Michael ^a   Claus, Ralf A ^a   Huber, Otmar ^a   Mosig, Alexander S ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINOID; APOLIPOPROTEIN B; CADHERIN; CYTOKINE; LEUKOCYTE ANTIGEN; LIPOPOLYSACCHARIDE; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; TOLL LIKE RECEPTOR; VASCULAR ENDOTHELIAL CADHERIN;

BIOLOGICAL MODEL; CAPILLARY; CELL COMMUNICATION; COCULTURE; CYTOLOGY; CYTOPLASM; DRUG EFFECTS; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; LAB ON A CHIP; LIVER; LIVER CELL; MONOCYTE; SIGNAL TRANSDUCTION;

ALBUMINS; ANTIGENS, CD; APOLIPOPROTEINS B; CADHERINS; CAPILLARIES; CELL COMMUNICATION; COCULTURE TECHNIQUES; CYTOKINES; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; INFLAMMATION; LAB-ON-A-CHIP DEVICES; LIPOPOLYSACCHARIDES; LIVER; MODELS, BIOLOGICAL; MONOCYTES; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; ORGANOIDS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84959422304     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep46988     Document Type: Erratum

References (66)

1. Bauer, M., Press, A. T., Trauner, M. The liver in sepsis: patterns of response and injury. Curr. Opin. Crit. Care 19, 123-7 (2013).
2. Recknagel, P. et al. Liver Dysfunction and Phosphatidylinositol-3-Kinase Signalling in Early Sepsis: Experimental Studies in Rodent Models of Peritonitis. PLoS Med 9, 9-10 (2012).
3. Ring, a & Stremmel, W. The hepatic microvascular responses to sepsis. Semin. Thromb. Hemost. 26, 589-94 (2000).
4. Seok, J. et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 110, 3507-3512 (National Acad Sciences, 2013).
5. Takao, K., Miyakawa, T. Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc Natl Acad Sci USA 112, 1401965111-(2014).
6. Bouwens, L., Baekeland, M., De Zanger, R., Wisse, E. Quantitation, tissue distribution and proliferation kinetics of Kupffer cells in normal rat liver. Hepatology 6, 718-722 (1986).
7. Seki, E. et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13, 1324-1332 (2007).
8. Kmiec, Z., Kmie?, Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 161, III-XIII, 1-151 (2001).
9. Kordes, C., Sawitza, I., Haussinger, D., Haüssinger, D. Hepatic and pancreatic stellate cells in focus. Biol Chem 390, 1003-1012 (2009).
10. Weiskirchen, R., Tacke, F. Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. Hepatobiliary Surg Nutr 3, 344-363 (2014).
11. Godoy, P. et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and nonparenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 87, 1315-1530 (2013).
12. LeCluyse, E. L., Witek, R. P., Andersen, M. E., Powers, M. J. Organotypic liver culture models: Meeting current challenges in toxicity testing. Crit. Rev. Toxicol. 42, 501-548 (2012).
13. Osuchowski, M. F., Craciun, F., Weixelbaumer, K. M., Duffy, E. R., Remick, D. G. Sepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis. J Immunol 189, 4648-4656 (2012).
14. Toh, Y.-C. C. et al. A microfluidic 3D hepatocyte chip for drug toxicity testing. Lab Chip 9, 2026-2035 (2009).
15. Messner, S., Agarkova, I., Moritz, W., Kelm, J. M. Multi-cell type human liver microtissues for hepatotoxicity testing. Arch Toxicol 87, 209-213 (2013).
16. Wagner, I. et al. A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture. Lab Chip 13, 3538-3547 (2013).
17. Rennert, K. et al. A microfluidically perfused three dimensional human liver model. Biomaterials 71, 119-131 (2015).
18. Raasch, M. et al. Microfluidically supported biochip design for culture of endothelial cell layers with improved perfusion conditions. Biofabrication 7, 15013 (2015).
19. Hotchkiss, R. S., Monneret, G., Payen, D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13, 862-874 (2013).
20. Cerec, V. et al. Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology 45, 957-967 (2007).
21. Aninat, C. et al. Catecholamines induce an inflammatory response in human hepatocytes. Crit Care Med 36, 848-54 (2008).
22. Rubin, L. L. et al. A cell culture model of the blood-brain barrier. J. Cell Biol. 115, 1725-1735 (1991).
23. Wake, K. Hepatic stellate cells: Three-dimensional structure, localization, heterogeneity and development. Proc Jpn Acad Ser B Phys Biol Sci 82, 155-164 (2006).
24. Guillouzo, A., Guguen-Guillouzo, C. Evolving concepts in liver tissue modeling and implications for in vitro toxicology. Expert Opin. Drug Metab. Toxicol. 4, 1279-1294 (2008).
25. Klein, M. et al. A Systematic Comparison of the Impact of Inflammatory Signaling on Absorption, Distribution, Metabolism, and Excretion Gene Expression and Activity in Primary Human Hepatocytes and HepaRG Cells. Drug Metab Dispos 43, 273-283 (2015).
26. Denis, C. V. Molecular and cellular biology of von Willebrand factor. Int J Hematol 75, 3-8 (2002).
27. Privratsky, J. R., Newman, D. K., Newman, P. J. PECAM-1: conflicts of interest in inflammation. Life Sci 87, 69-82 (2010).
28. Khetani, S. R., Bhatia, S. N. Microscale culture of human liver cells for drug development. Nat. Biotechnol. 26, 120-6 (2008).
29. Luo, G., Guenthner, T., Gan, L. S., Humphreys, W. G. CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and development. Curr Drug Metab 5, 483-505 (2004).
30. Moriya, N., Kataoka, H., Fujino, H., Nishikawa, J., Kugawa, F. Different expression patterns of hepatic cytochrome P450 s during anaphylactic or lipopolysaccharide-induced inflammation. Pharmazie 69, 1-6 (2014).
31. Levels, J. H. M., Lemaire, L. C. J. M., van den Ende, A. E., van Deventer, S. J. H., van Lanschot, J. J. B. Lipid composition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with systemic inflammatory response syndrome and multiple organ failure. Crit Care Med 31, 1647-1653 (2003).
32. Geier, A., Fickert, P., Trauner, M. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pr. Gastroenterol Hepatol 3, 574-585 (2006).
33. Zamek-Gliszczynski, M. J. et al. Pharmacokinetics of 5 (and 6)-carboxy-2? ,7?-dichlorofluorescein and its diacetate promoiety in the liver. J. Pharmacol. Exp. Ther. 304, 801-9 (2003).
34. Aird, W. C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101, 3765-3777 (2003).
35. van Oosten, M., van de Bilt, E., van Berkel, T. J., Kuiper, J. New scavenger receptor-like receptors for the binding of lipopolysaccharide to liver endothelial and Kupffer cells. Infect Immun 66, 5107-5112 (1998).
36. Géraud, C. et al. Unique cell type-specific junctional complexes in vascular endothelium of human and rat liver sinusoids. PLoS One 7, e34206 (2012).
37. Desai, T. R., Leeper, N. J., Hynes, K. L., Gewertz, B. L. Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway. J Surg Res 104, 118-123 (2002).
38. Kjaergaard, A. G., Dige, A., Krog, J., Tonnesen, E., Wogensen, L. Soluble Adhesion Molecules Correlate with Surface Expression in an In Vitro Model of Endothelial Activation. Basic & Clinical Pharmacology & Toxicology 113, 273-279 (2013).
39. Wang, H. E. et al. Inflammatory and endothelial activation biomarkers and risk of sepsis: a nested case-control study. J Crit Care 28, 549-555 (2013).
40. Nomura, Y. et al. Phenotype for activated tissue macrophages in histiocytic necrotizing lymphadenitis. Pathol. Int. 59, 631-5 (2009).
41. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A. Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555 (2002).
42. Gonnert, F. A. et al. Hepatic Fibrosis in a Long-term Murine Model of Sepsis. Shock 37, 399-407 (2012).
43. Gonnert, F. A. et al. Characteristics of clinical sepsis reflected in a reliable and reproducible rodent sepsis model. J. Surg. Res. 170, e123-34 (2011).
44. Otto, G. P. et al. Impact of antibiotic treatment intensity on long-term sepsis-associated kidney injury in a polymicrobial peritoneal contamination and infection model. Nephron 129, 137-42 (2015).
45. Recknagel, P., Claus, R. A., Neugebauer, U., Bauer, M., Gonnert, F. A. In vivo imaging of hepatic excretory function in the rat by fluorescence microscopy. J Biophotonics 5, 571-81 (2012).
46. Aitken, A. E., Morgan, E. T. Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes. Drug Metab Dispos 35, 1687-1693 (2007).
47. Lekkou, A., Mouzaki, A., Siagris, D., Ravani, I., Gogos, C. A. Serum lipid profile, cytokine production, and clinical outcome in patients with severe sepsis. J. Crit. Care 29, 723-7 (2014).
48. Figueras-Aloy, J. et al. Serum soluble ICAM-1, VCAM-1, L-selectin, and P-selectin levels as markers of infection and their relation to clinical severity in neonatal sepsis. Am J Perinatol 24, 331-338 (2007).
49. Billiar, T. R., Curran, R. D., Williams, D. L., Kispert, P. H. Liver nonparenchymal cells are stimulated to provide interleukin 6 for induction of the hepatic acute-phase response in endotoxemia but not in remote localized inflammation. Arch Surg 127, 31-37 (1992).
50. Harvey, S. A. K., Dangi, A., Tandon, A., Gandhi, C. R. The transcriptomic response of rat hepatic stellate cells to endotoxin: implications for hepatic inflammation and immune regulation. PLoS One 8, e82159 (2013).
51. Schildberger, A., Rossmanith, E., Eichhorn, T., Strassl, K., Weber, V. Monocytes, peripheral blood mononuclear cells, and THP-1 cells exhibit different cytokine expression patterns following stimulation with lipopolysaccharide. Mediators Inflamm. 697972, 697972 (2013).
52. Makó, V. et al. Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL-1? , TNF-? , and LPS. Cytom. Part A 77A, 962-970 (2010).
53. Lawson, C., Wolf, S. ICAM-1 signaling in endothelial cells. Pharmacol. Rep. 61, 22-32 (2009).
54. Campion, S. N. et al. Hepatic Mrp4 induction following acetaminophen exposure is dependent on Kupffer cell function. Am J Physiol Gastrointest Liver Physiol 295, G294-304 (2008).
55. Holt, M. P., Cheng, L., Ju, C. Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J Leukoc Biol 84, 1410-1421 (2008).
56. Tacke, F., Zimmermann, H. W. Macrophage heterogeneity in liver injury and fibrosis. J Hepatol 60, 1-17 (2014).
57. Porcheray, F. et al. Macrophage activation switching: An asset for the resolution of inflammation. Clin. Exp. Immunol. 142, 481-489 (2005).
58. Murray, P. J., Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11, 723-737 (2011).
59. Shalova, I. N. et al. Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1alpha. Immunity 42, 484-498 (2015).
60. Esch, M. B. et al. Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow. Lab Chip 15, 2269-2277 (2015).
61. Prodanov, L. et al. Long-term maintenance of a microfluidic 3D human liver sinusoid. Biotechnol. Bioeng. 113, 1-10 (2015).
62. Hotchkiss, R. S., Opal, S. Immunotherapy for sepsis-a new approach against an ancient foe. N Engl J Med 363, 87-89 (2010).
63. Gripon, P. et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci USA 99, 15655-15660 (2002).
64. Jaffe, E. A., Nachman, R. L., Becker, C. G., Minick, C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52, 2745-56 (1973).
65. Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).
66. Klinger, W., Müller, D. Ethylmorphine-N-demethylation by liver homogenate of newborn and adult rats; Enzyme kinetics and age course of Vmax and Km1. Acta Biol. Med. Ger. 36, 1149-59 (1977).